Previous study suggest that CML EVs can freely and invasively deliver BCR/ABL gene from CML cells into normal neutrophils and then influence their function in the bone marrow. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.